LLY

1,126.9

+3.46%↑

JNJ

228.18

+1.98%↑

ABBV

223.21

+2.13%↑

UNH

395.46

+3.74%↑

MRK

119.52

+3.94%↑

LLY

1,126.9

+3.46%↑

JNJ

228.18

+1.98%↑

ABBV

223.21

+2.13%↑

UNH

395.46

+3.74%↑

MRK

119.52

+3.94%↑

LLY

1,126.9

+3.46%↑

JNJ

228.18

+1.98%↑

ABBV

223.21

+2.13%↑

UNH

395.46

+3.74%↑

MRK

119.52

+3.94%↑

LLY

1,126.9

+3.46%↑

JNJ

228.18

+1.98%↑

ABBV

223.21

+2.13%↑

UNH

395.46

+3.74%↑

MRK

119.52

+3.94%↑

LLY

1,126.9

+3.46%↑

JNJ

228.18

+1.98%↑

ABBV

223.21

+2.13%↑

UNH

395.46

+3.74%↑

MRK

119.52

+3.94%↑

Home・Aktien・Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc

Open

BrancheGesundheitswesen

21.45

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

Max

Schlüsselkennzahlen
By Trading Economics
Einkommen	-1.6M -21M
Verkäufe	14M 54M
Gewinnspanne	-39.611
Angestellte	178
EBITDA	-7.7M -26M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	-3.62% downside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	1B 2.2B
Vorheriger Eröffnungskurs	21.45
Vorheriger Schlusskurs	21.45

Nachrichtenstimmung

By Acuity

50%

154 / 344 Ranking in Healthcare

Day One Biopharmaceuticals Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Juni 2026, 23:22 UTC

Ergebnisse

Wichtige Markttreiber

Broadcom Shares Slide Despite Jump in 2Q Revenue on AI Chip Demand -- Update

3. Juni 2026, 23:09 UTC

Heiße Aktien

Stocks to Watch: Broadcom, CrowdStrike, PVH, Petco

3. Juni 2026, 20:51 UTC

Ergebnisse

Costco Reports 15% Sales Growth in May

3. Juni 2026, 20:43 UTC

Ergebnisse

Broadcom 2Q Revenue Climbs on AI Chip Demand

3. Juni 2026, 23:48 UTC

Market Talk

Nikkei May Fall Amid Renewed Concerns About Iran Conflict -- Market Talk

3. Juni 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3. Juni 2026, 23:35 UTC

Market Talk

Oil Futures Fall on Possible Technical Correction -- Market Talk

3. Juni 2026, 23:15 UTC

Market Talk

Ergebnisse

Five Below, Broadcom and Crowdstrike Fall Despite Solid Results -- Market Talk

3. Juni 2026, 22:08 UTC

Heiße Aktien

After-Hours Stocks to Watch: CrowdStrike, Broadcom, Five Below -- WSJ

3. Juni 2026, 21:54 UTC

Market Talk

Correction to Oil Futures Rise on Concerns About U.S.-Iran Talks Article on June 1

3. Juni 2026, 21:18 UTC

Ergebnisse

Broadcom's Non-AI Semiconductor Revenue Rose 6% in 2Q, CEO Says

3. Juni 2026, 21:15 UTC

Ergebnisse

Broadcom CEO: Google Partnership Continues to Be 'Very Substantial'

3. Juni 2026, 21:13 UTC

Ergebnisse

Broadcom CEO Expects AI Semiconductor Revenue Growth to Continue in Fiscal 2028

3. Juni 2026, 21:13 UTC

Ergebnisse

Broadcom Continues to Expect AI Semiconductor Revenue of More Than $100B in 2027, CEO Says

3. Juni 2026, 21:12 UTC

Ergebnisse

Broadcom Expects AI Semiconductor Revenue of $56B This Year, CEO Says

3. Juni 2026, 21:09 UTC

Ergebnisse

Broadcom CEO: Networking Made Up Almost 40% of AI Revenue in 2Q

3. Juni 2026, 21:03 UTC

Ergebnisse

Broadcom Stock Falls After Earnings. Here's Why. -- Barrons.com

3. Juni 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3. Juni 2026, 20:43 UTC

Ergebnisse

CrowdStrike Stock Falls Despite Earnings Beat -- Barrons.com

3. Juni 2026, 20:39 UTC

Akquisitionen, Fusionen, Übernahmen

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- 4th Update

3. Juni 2026, 20:37 UTC

Akquisitionen, Fusionen, Übernahmen

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- 3rd Update

3. Juni 2026, 20:35 UTC

Ergebnisse

Broadcom Stock Falls Despite Record Results -- Barrons.com

3. Juni 2026, 20:21 UTC

Akquisitionen, Fusionen, Übernahmen

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- 2nd Update

3. Juni 2026, 20:17 UTC

Ergebnisse

Broadcom 2Q Semiconductor Solutions Revenue $15B >AVGO

3. Juni 2026, 20:17 UTC

Ergebnisse

Broadcom Sees 3Q Semiconductor Revenue From AI $16B >AVGO

3. Juni 2026, 20:15 UTC

Akquisitionen, Fusionen, Übernahmen

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- Update

3. Juni 2026, 20:15 UTC

Ergebnisse

Broadcom 2Q Adj EPS $2.44 >AVGO

3. Juni 2026, 20:15 UTC

Ergebnisse

Broadcom 2Q EPS $1.91 >AVGO

3. Juni 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

3. Juni 2026, 20:15 UTC

Ergebnisse

Broadcom 2Q Rev $22.19B >AVGO

Peer-Vergleich

Kursveränderung

Day One Biopharmaceuticals Inc Prognose

Kursziel

By TipRanks

-3.62% Nachteil

12-Monats-Prognose

Durchschnitt 20.75 USD -3.62%

Hoch 21.5 USD

Tief 17 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Day One Biopharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

7 ratings

Buy

Halten

Sell

Basierend auf 7 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Day One Biopharmaceuticals Inc – Dist abgegeben haben.

Stimmung

By Acuity

154 / 344 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.